Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.

Quartuccio N, Evangelista L, Alongi P, Caobelli F, Altini C, Cistaro A, Lambertini A, Schiorlin I, Popescu CE, Linguanti F, Laudicella R, Scalorbi F, Di Pierro G, Asabella AN, Cuppari L, Margotti S, Lima GM, Scalisi S, Pacella S, Kokomani A, Ciaccio A, Sturiale L, Vento A, Cardile D, Baldari S, Panareo S, Fanti S, Rubini G, Schillaci O, Chiaravalloti A; Young AIMN Working Group.

Nucl Med Commun. 2019 Aug;40(8):808-814. doi: 10.1097/MNM.0000000000001038.

PMID:
31136534
2.

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

Calvo A, Chiò A, Pagani M, Cammarosano S, Dematteis F, Moglia C, Solero L, Manera U, Martone T, Brunetti M, Balma M, Castellano G, Barberis M, Cistaro A, Artusi CA, Vasta R, Montanaro E, Romagnolo A, Iazzolino B, Canosa A, Carrara G, Valentini C, Li TQ, Nobili F, Lopiano L, Rizzone MG.

J Neurol. 2019 Jul;266(7):1633-1642. doi: 10.1007/s00415-019-09305-0. Epub 2019 Apr 4.

PMID:
30949819
3.

Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.

Marini C, Morbelli S, Cistaro A, Campi C, Caponnetto C, Bauckneht M, Bellini A, Buschiazzo A, Calamia I, Beltrametti MC, Margotti S, Fania P, Poggi I, Cabona C, Capitanio S, Piva R, Calvo A, Moglia C, Canosa A, Massone A, Nobili F, Mancardi G, Chiò A, Piana M, Sambuceti G.

Brain. 2018 Aug 1;141(8):2272-2279. doi: 10.1093/brain/awy152.

4.

Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.

Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chiò A, Cistaro A, Perani D.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1117-1131. doi: 10.1007/s00259-018-4246-2. Epub 2019 Jan 7.

PMID:
30617963
5.

Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis.

Canosa A, Pagani M, Brunetti M, Barberis M, Iazzolino B, Ilardi A, Cammarosano S, Manera U, Moglia C, Calvo A, Cistaro A, Chiò A.

Eur J Neurol. 2019 Feb;26(2):306-312. doi: 10.1111/ene.13812. Epub 2018 Oct 24.

PMID:
30240096
6.

FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.

Lopci E, Mascarin M, Piccardo A, Castello A, Elia C, Guerra L, Borsatti E, Sala A, Todesco A, Zucchetta P, Farruggia P, Cistaro A, Buffardi S, Bertolini P, Bianchi M, Moleti ML, Bunkheila F, Indolfi P, Fagioli F, Garaventa A, Burnelli R; AIEOP Hodgkin Lymphoma Study Group, Italy.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):97-106. doi: 10.1007/s00259-018-4155-4. Epub 2018 Sep 15.

PMID:
30219963
7.

Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.

Chiavazza C, Pellerino A, Ferrio F, Cistaro A, Soffietti R, Rudà R.

Biomed Res Int. 2018 Jun 21;2018:3606970. doi: 10.1155/2018/3606970. eCollection 2018. Review.

8.

Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy.

Scabini S, Trunfio M, Pirriatore V, Imperiale D, Audagnotto S, Bertucci R, Ghisetti V, Cinnirella G, Cistaro A, Perna M, Calcagno A, Di Perri G.

Infez Med. 2018 Jun 1;26(2):160-163.

9.

Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls.

D'hulst L, Van Weehaeghe D, Chiò A, Calvo A, Moglia C, Canosa A, Cistaro A, Willekens SM, De Vocht J, Van Damme P, Pagani M, Van Laere K.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):570-577. doi: 10.1080/21678421.2018.1476548. Epub 2018 Jun 4.

PMID:
29862846
10.

Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.

Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G.

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e267-e273. doi: 10.1016/j.clml.2018.04.002. Epub 2018 Apr 14.

PMID:
29739722
11.

Locked-in Syndrome and 18F-fluorodeoxyglucose-positron Emission Tomography/Computed Tomography: Observations from a Case of Basilar Artery Thrombosis.

Cistaro A, Lo Bianco G, Fania P, Margotti S, Vigneri S, Geraci C, Quartuccio N.

Indian J Nucl Med. 2018 Jan-Mar;33(1):65-67. doi: 10.4103/ijnm.IJNM_85_17.

12.

Radiotracers for Amyloid Imaging in Neurodegenerative Disease: State-of-the-Art and Novel Concepts.

Cistaro A, Alongi P, Caobelli F, Cassalia L.

Curr Med Chem. 2018;25(26):3131-3140. doi: 10.2174/0929867325666180117094704. Review.

PMID:
29345576
13.

Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma.

Valentini MC, Mellai M, Annovazzi L, Melcarne A, Denysenko T, Cassoni P, Casalone C, Maurella C, Grifoni S, Fania P, Cistaro A, Schiffer D.

Oncotarget. 2017 Oct 4;8(53):91636-91653. doi: 10.18632/oncotarget.21482. eCollection 2017 Oct 31.

14.

A Rare Case of Hibernoma Occasionally Identified by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Patient with Lung Cancer.

Penna D, Quartuccio N, Testa C, Arena V, Cistaro A, Pelosi E.

Cureus. 2017 Mar 29;9(3):e1124. doi: 10.7759/cureus.1124.

15.

MRI and 18F-FDG-PET/CT in a rare case of early (precursor) B-lymphoblastic leukaemia with bone involvement as initial manifestation.

Cistaro A, La Delfa V, Di Rosa G, Cogoni M, Quartuccio N.

Nucl Med Rev Cent East Eur. 2017;20(1):57-59. doi: 10.5603/NMR.2017.0004.

16.

Prevention of dental caries: A review of effective treatments.

Sicca C, Bobbio E, Quartuccio N, Nicolò G, Cistaro A.

J Clin Exp Dent. 2016 Dec 1;8(5):e604-e610. eCollection 2016 Dec. Review.

17.

Brain 18F-FDG PET/CT findings in a case of genetic Creutzfeldt-Jakob disease due to V203I heterozygous mutation in the PRNP gene.

Cistaro A, Cassalia L, Ferrara C, Atzori C, Vai D, Quartuccio N, Fania P, Vaudano GP, Imperiale D.

J Neurol. 2017 Jan;264(1):170-173. doi: 10.1007/s00415-016-8327-5. Epub 2016 Nov 14. No abstract available.

PMID:
27844164
18.

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.

Chiavazza C, Cistaro A, Fania P, Bertolotto A, Cavalla P, Rudà R, Pinessi L, Soffietti R.

Neurol Sci. 2016 Dec;37(12):2019-2023. Epub 2016 Jul 25. No abstract available.

PMID:
27457655
19.

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.

Marini C, Cistaro A, Campi C, Calvo A, Caponnetto C, Nobili FM, Fania P, Beltrametti MC, Moglia C, Novi G, Buschiazzo A, Perasso A, Canosa A, Scialò C, Pomposelli E, Massone AM, Bagnara MC, Cammarosano S, Bruzzi P, Morbelli S, Sambuceti G, Mancardi G, Piana M, Chiò A.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2061-71. doi: 10.1007/s00259-016-3440-3. Epub 2016 Jul 15.

20.

Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results.

Panichelli P, Villano C, Cistaro A, Bruno A, Barbato F, Piccardo A, Duatti A.

Cancer Biother Radiopharm. 2016 Jun;31(5):159-67. doi: 10.1089/cbr.2016.2028. Epub 2016 May 26.

PMID:
27228278
21.

(18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.

Cistaro A, Cucinotta M, Cassalia L, Priola A, Priola S, Pappalardo M, Coppolino P, De Simone M, Quartuccio N.

Rev Esp Med Nucl Imagen Mol. 2016 Jul-Aug;35(4):232-7. doi: 10.1016/j.remn.2016.01.001. Epub 2016 Feb 19. English, Spanish.

PMID:
26907833
22.

Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis.

Pagani M, Öberg J, De Carli F, Calvo A, Moglia C, Canosa A, Nobili F, Morbelli S, Fania P, Cistaro A, Chiò A.

Hum Brain Mapp. 2016 Mar;37(3):942-53. doi: 10.1002/hbm.23078. Epub 2015 Dec 24.

PMID:
26703938
23.

18F-FDG-PET correlates of cognitive impairment in ALS.

Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, Cammarosano S, Ilardi A, Moglia C, Calvo A, Chiò A.

Neurology. 2016 Jan 5;86(1):44-9. doi: 10.1212/WNL.0000000000002242. Epub 2015 Nov 20.

PMID:
26590270
24.

124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.

Cistaro A, Quartuccio N, Caobelli F, Piccardo A, Paratore R, Coppolino P, Sperandeo A, Arnone G, Ficola U.

Nucl Med Rev Cent East Eur. 2015;18(2):102-6. doi: 10.5603/NMR.2015.0024.

25.

Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.

Cistaro A, Niccoli Asabella A, Coppolino P, Quartuccio N, Altini C, Cucinotta M, Alongi P, Balma M, Sanfilippo S, Buschiazzo A, Piccardo A, Fanelli M, Sambuceti G, Bomanji J, Baldari S, Bisi G, Fanti S, Rubini G.

Hell J Nucl Med. 2015 May-Aug;18(2):97-102. doi: 10.1967/s002449910202. Epub 2015 Jun 29.

26.

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Mellai M, Piazzi A, Casalone C, Grifoni S, Melcarne A, Annovazzi L, Cassoni P, Denysenko T, Valentini MC, Cistaro A, Schiffer D.

Onco Targets Ther. 2015 Feb 19;8:451-60. doi: 10.2147/OTT.S71384. eCollection 2015.

27.

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.

Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H.

AJR Am J Roentgenol. 2015 Jan;204(1):153-60. doi: 10.2214/AJR.14.12932.

PMID:
25539251
28.

Uncommon 18F-FDG-PET/CT findings in patients affected by limbic encephalitis: hyper-hypometabolic pattern with double antibody positivity and migrating foci of hypermetabolism.

Cistaro A, Caobelli F, Quartuccio N, Fania P, Pagani M.

Clin Imaging. 2015 Mar-Apr;39(2):329-33. doi: 10.1016/j.clinimag.2014.09.004. Epub 2014 Oct 16.

PMID:
25487436
29.

Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes.

Chiò A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M.

Lancet Neurol. 2014 Dec;13(12):1228-40. doi: 10.1016/S1474-4422(14)70167-X. Epub 2014 Nov 10. Review.

PMID:
25453462
30.

Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?

Quartuccio N, Van Weehaeghe D, Cistaro A, Jonsson C, Van Laere K, Pagani M.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):344-54. Epub 2014 Nov 6. Review.

31.

Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.

Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, Rubini D, Cistaro A, Montemurro S, Rubini G.

Abdom Imaging. 2015 Jun;40(5):1190-202. doi: 10.1007/s00261-014-0277-8.

PMID:
25348731
32.

A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.

Cucinotta M, Quartuccio N, Coppolino P, La Delfa V, Bianchi M, Fagioli F, Cistaro A.

Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):e201-5. doi: 10.1016/j.clml.2014.06.106. Epub 2014 Aug 15. No abstract available.

PMID:
25240649
33.

Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.

Pagani M, Chiò A, Valentini MC, Öberg J, Nobili F, Calvo A, Moglia C, Bertuzzo D, Morbelli S, De Carli F, Fania P, Cistaro A.

Neurology. 2014 Sep 16;83(12):1067-74. doi: 10.1212/WNL.0000000000000792. Epub 2014 Aug 13.

PMID:
25122207
34.

Role of PET and SPECT in the study of amyotrophic lateral sclerosis.

Cistaro A, Cuccurullo V, Quartuccio N, Pagani M, Valentini MC, Mansi L.

Biomed Res Int. 2014;2014:237437. doi: 10.1155/2014/237437. Epub 2014 Apr 10. Review.

35.

¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, Giubbini R, Naseri M, Cistaro A, Cabria M, Bardesono F, Ceriani L, Orlandi F, Giovanella L.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91. doi: 10.1007/s00259-014-2774-y. Epub 2014 Apr 30.

PMID:
24781870
36.

A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment.

Canosa A, Calvo A, Moglia C, Iazzolino B, Brunetti M, Restagno G, Cistaro A, Fania P, Carrara G, Valentini MC, Tanel R, Chiò A.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1437-9. doi: 10.1136/jnnp-2013-307552. Epub 2014 Apr 25. No abstract available.

PMID:
24769475
37.

Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1046-56. doi: 10.1007/s00259-014-2691-0. Epub 2014 Feb 22.

PMID:
24562643
38.

The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.

Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):844-52. doi: 10.1007/s00259-013-2667-5. Epub 2014 Jan 21.

39.

Is %ΔSUVmax a useful indicator of survival in patients with advanced nonsmall-cell lung cancer?

Cistaro A, Quartuccio N, Mojtahedi A, Fania P, Filosso PL, Cucinotta M, Campennì A, Ficola U, Baldari S.

ScientificWorldJournal. 2013 Oct 9;2013:910957. doi: 10.1155/2013/910957. eCollection 2013.

40.

Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification.

Cistaro A, Quartuccio N, Mojtahedi A, Fania P, Filosso PL, Campenni A, Ficola U, Baldari S.

Radiol Oncol. 2013 Jul 30;47(3):219-23. doi: 10.2478/raon-2013-0023. eCollection 2013.

41.

A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.

Cistaro A, Treglia G, Pagano M, Fania P, Bova V, Basso ME, Fagioli F, Ficola U, Quartuccio N.

Biomed Res Int. 2013;2013:709037. doi: 10.1155/2013/709037. Epub 2013 Aug 26.

42.

Autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma: what 18F-fluorodeoxyglucose positron emission tomography/computed tomography can do in the management of these patients? Suggestions from a case report.

Cistaro A, Pazè F, Durando S, Cogoni M, Faletti R, Vesco S, Vallero S, Quartuccio N, Treglia G, Ramenghi U.

Rev Esp Med Nucl Imagen Mol. 2014 Mar-Apr;33(2):99-102. doi: 10.1016/j.remn.2013.05.008. Epub 2013 Jul 9.

PMID:
23845452
43.

The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma.

Quartuccio N, Treglia G, Salsano M, Mattoli MV, Muoio B, Piccardo A, Lopci E, Cistaro A.

Radiol Oncol. 2013 May 21;47(2):97-102. doi: 10.2478/raon-2013-0017. Print 2013 Jun.

44.

Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.

Piccardo A, Lopci E, Conte M, Cabria M, Cistaro A, Garaventa A, Villavecchia G.

Clin Nucl Med. 2014 Jan;39(1):e80-3. doi: 10.1097/RLU.0b013e31827a0002.

PMID:
23579975
45.

PET/CT imaging in neuroblastoma.

Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):29-39. Review.

PMID:
23474633
46.

PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?

Skanjeti A, Penna D, Douroukas A, Cistaro A, Arena V, Leo G, Longo G, Traverso A, Belloro S, Pelosi E.

Q J Nucl Med Mol Imaging. 2012 Dec;56(6):569-76.

PMID:
23358410
47.

Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.

Treglia G, Quartuccio N, Sadeghi R, Farchione A, Caldarella C, Bertagna F, Fania P, Cistaro A.

J Crohns Colitis. 2013 Jun;7(5):345-54. doi: 10.1016/j.crohns.2012.08.005. Epub 2012 Sep 7. Review.

48.

Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene.

Calvo A, Moglia C, Canosa A, Cistaro A, Valentini C, Carrara G, Soldano E, Ilardi A, Bersano E, Bertuzzo D, Brunetti M, Ossola I, Restagno G, Chiò A.

J Neurol. 2012 Dec;259(12):2723-5. doi: 10.1007/s00415-012-6640-1. Epub 2012 Aug 24. No abstract available.

PMID:
22918453
49.

Positron emission tomography.

Cistaro A, Quartuccio N, Vesco S, Pagani M, Fania P, Donati L, Nobili FM, Duca S, Carrara G, Valentini MC.

Ophthalmology. 2012 Jul;119(7):1496-7.e1. doi: 10.1016/j.ophtha.2012.02.047. No abstract available.

PMID:
22749089
50.

The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.

Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, Fagioli F.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1206-10. doi: 10.1002/pbc.24242. Epub 2012 Jun 28.

PMID:
22745027

Supplemental Content

Loading ...
Support Center